Talking about women’s health has been a taboo subject for some time, contributing to a lack of innovation in the sector. Still today … source
Full story on Bio.News: https://bio.news/federal-policy/2022-midterms-recap-what-happened-and-what-the-results-mean-for-biotech/ source
Full story on Bio. source
John Murphy, BIO’s Chief Policy Officer, discusses domestic manufacturing capabilities and building resilience into the supply … source
Plans to limit FDA’s Accelerated Approval (AA) pathway would reduce the number of new treatments hitting the market, especially … source
Dr. Christophe Schilling, Founder & CEO of Geno, and a member of BIO’s Ag and Environment Governing Board, testified at a … source
Watch this video and listen to the new #IamBIO podcast: Microbes, Bioplastics…and Art: Solutions to Plastic Pollution and find out … source
BIO’s Interim President and CEO, Rachel King, discusses her priorities at BIO. source